logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Acta Oncologica cover

Acta Oncologica

IF2.2
Papers73
Citations8897
Journal Papers 145
Publication Date
delete
Dosimetric comparison of intensity-modulated proton therapy and proton arc therapy for pediatric ependymoma
deleteACTA ONCOLOGICA
IF2.2
delete2025-05-12
delete0
deleteOAAI
deleteHenjum, H; Feten, KM; Hartvigsen, E; Ytre-Hauge, KS; Boer, CG; Stokkevåg, CH
deleteShare
deleteSave
Risk factors for rectal bleeding in prostate cancer after radiotherapy with a validation of current rectal dose constraints
deleteACTA ONCOLOGICA
IF2.2
delete2025-05-08
delete0
deleteOAAI
deleteRamanathan, C; Thomas, E; Henschen, AE; Adelman, JS; Zhang, YF
deleteShare
deleteSave
Clinical characteristics and treatment outcome in p16 negative anal cancer
deleteACTA ONCOLOGICA
IF2.2
delete2025-05-07
delete0
deleteOAAI
deleteBurgos, C; Radu, C; Heyman, S; Cavalli-Bjoerkman, N; Nygren, P
deleteShare
deleteSave
The risk of myelodysplastic syndrome and acute myeloid leukemia by metformin use and type 2 diabetes status-a Danish nation-wide cohort study
deleteACTA ONCOLOGICA
IF2.2
delete2025-05-07
delete0
deleteOAAI
deleteRotbain, EC; Rostgaard, K; Kaastrup, K; Mikkelsen, SU; Hjalgrim, H; Gronbaek, K
deleteShare
deleteSave
Patients with uHCC and Child-Pugh B8/9 also benefit from a combination of antiangiogenic agents and PD-1 inhibitors: a multicenter real-world study
deleteACTA ONCOLOGICA
IF2.2
delete2025-05-05
delete0
deleteOAAI
deleteDing, XY; Yin, X; Zheng, LL; Zhou, L; Hu, JK; Sun, W; Sun, L; Shen, YJ; Teng, Y; Xu, YW; Li, WD; Liu, M; Chen, JL
deleteShare
deleteSave
Evolution of treatment practices and outcomes in multiple myeloma during 2013-2022: a Finnish real world registry study
deleteACTA ONCOLOGICA
IF2.2
delete2025-05-05
delete0
deleteOAAI
deletePartanen, A; Waltari, M; Vikkula, J; Mattila, R; Naerhi, K; Eeva, J; Putkonen, M
deleteShare
deleteSave
Prevalence and management of immediate drug hypersensitivity observed during antineoplastic drug therapy
deleteACTA ONCOLOGICA
IF2.2
delete2025-04-28
delete0
deleteOAAI
deleteRasmussen, TH; Mortz, CG; Pfeiffer, P; Andersen, N; Bindslev-Jensen, C
deleteShare
deleteSave
Pre-treatment tumour PET metrics and clinical outcomes of anal cancer in patients living with and without HIV
deleteACTA ONCOLOGICA
IF2.2
delete2025-04-24
delete0
deleteOAAI
deletePennock, M; Brodin, NP; Velten, C; Gjini, M; Ohri, N; Guha, C; Kalnicki, S; Tomé, WA; Garg, MK; Kabarriti, R
deleteShare
deleteSave
The use of pegylated liposomal doxorubicin in metastatic soft tissue sarcoma
deleteACTA ONCOLOGICA
IF2.2
delete2025-04-23
delete0
deleteOAAI
deletePham, T; Rose, HK; Rossen, P; Aggerholm-Pedersen, N
deleteShare
deleteSave
Survival outcomes in hormone receptor-negative breast cancer among BRCA carriers versus noncarriers in western Sweden
deleteACTA ONCOLOGICA
IF2.2
delete2025-04-16
delete0
deleteOAAI
deleteTzikas, Anna-Karin; Holmberg, Erik; Parris, Toshima Z.; Kovacs, Aniko; Lovmar, Lovisa; Karlsson, Per
deleteShare
deleteSave
Treating intrahepatic cholangiocarcinoma with pemigatinib: two case reports of Nordic patients
deleteACTA ONCOLOGICA
IF2.2
delete2025-04-15
delete0
deleteOAAI
deleteVäliaho, VT; Spanggaard, I
deleteShare
deleteSave
Comparison of nab-paclitaxel, paclitaxel, and oxaliplatin-induced peripheral neuropathy: a cross-sectional cohort study
deleteACTA ONCOLOGICA
IF2.2
delete2025-04-15
delete0
deleteOAAI
deleteTrinh, T; Au, K; Krishnan, A; Timmins, HC; Li, T; Grimison, P; Goldstein, D; Park, SB
deleteShare
deleteSave
Long-term trends in the clinical management and outcomes of patients with gastroesophageal cancer in Norway
deleteACTA ONCOLOGICA
IF2.2
delete2025-04-15
delete0
deleteOAAI
deleteKolstad, AB; Emanuel, G; Hjortland, GO; Nilssen, Y; Ulvestad, M; Areffard, A; Aahlin, EK
deleteShare
deleteSave
Quality of life in older patients with cancer and related unmet needs: a scoping review
deleteACTA ONCOLOGICA
IF2.2
delete2025-04-15
delete0
deleteOAAI
deleteSpringer, F; Matsuoka, A; Obama, K; Mehnert-Theuerkauf, A; Uchitomi, Y; Fujimori, M
deleteShare
deleteSave
Cardiotoxicity in patients with metastatic melanoma treated with BRAF/MEK inhibitors: a real-world analysis of incidence, risk factors, and reversibility
deleteACTA ONCOLOGICA
IF2.2
delete2025-04-13
delete0
deleteOAAI
deleteOddershede, JK; Meklenborg, IK; Bastholt, L; Guldbrandt, LM; Schmidt, H; Friis, RB
deleteShare
deleteSave
Association of health literacy with cancer survival: a single-centre prospective cohort study
deleteACTA ONCOLOGICA
IF2.2
delete2025-04-02
delete0
deleteOAAI
deleteSandström, N; Jekunen, A; Johansson, M; Andersén, H
deleteShare
deleteSave
The effect of exercise in patients with lower limb lymphedema: a systematic review
deleteACTA ONCOLOGICA
IF2.2
delete2025-03-31
delete0
deleteOAAI
deleteWittenkamp, MC; Christensen, J; Vinther, A; Juhl, CB
deleteShare
deleteSave
Survivor-driven development of a PROM for use in routine colorectal cancer care
deleteACTA ONCOLOGICA
IF2.2
delete2025-03-27
delete0
deleteOAAI
deleteLyhne, J; Gade, L; Hansen, L; Johansen, A; Smith, A; Jensen, LH; Ventzel, L
deleteShare
deleteSave
Treatment group-specific inferences in Phase III Randomized Oncology Trials
deleteACTA ONCOLOGICA
IF2.2
delete2025-03-24
delete0
deleteOAAI
deleteSherry, AD; Passy, AH; Jaoude, JA; Lin, TA; Kouzy, R; Msaouel, P; Ludmir, EB
deleteShare
deleteSave
Treatment decision-making and treatment experiences in men with metastatic castration-resistant prostate cancer
deleteACTA ONCOLOGICA
IF2.2
delete2025-03-24
delete0
deleteOAAI
deleteDoveson, S; Fransson, P; Axelsson, L; Wennman-Larsen, A
deleteShare
deleteSave